43. Iso, H., et al. “The Relationship Between Green Tea and Total Caffeine Intake and Risk for Self-Reported Type 2 Diabetes Among Japanese Adults.” Annals of Internal Medicine 144, no. 8 (2006): 554–562.
44. DiNicolantonio, J. J., S. C. Lucan, and J. H. O’Keefe. “Is Coffee Harmful? If Looking for Longevity, Say Yes to the Coffee, No to the Sugar.” Mayo Clinic Proceedings 89, no. 4 (2014): 576–577.
45. Wedick, N. M., et al. “Effects of Caffeinated and Decaffeinated Coffee on Biological Risk Factors for Type 2 Diabetes: A Randomized Controlled Trial.” Nutrition Journal 10 (2011): 93.
46. O’Keefe, J. H., J. J. DiNicolantonio, and C. J. Lavie. “Coffee for Cardioprotection and Longevity.” Progress in Cardiovascular Disease 61, no. 1 (2018).
47. de Koning Gans, J. M., et al. “Tea and Coffee Consumption and Cardiovascular Morbidity and Mortality.” Arteriosclerosis, Thrombosis, and Vascular Biology 30, no. 8 (2010): 1665–1671.
48. Poole, R., et al. “Coffee Consumption and Health: Umbrella Review of Meta-Analyses of Multiple Health Outcomes.” The BMJ 359 (2017): j5024.
49. Gunter, M. J., et al. “Coffee Drinking and Mortality in 10 European Countries: A Multinational Cohort Study.” Annals of Internal Medicine 167, no. 4 (2017): 236–247.
50. Ding, M., et al. “Association of Coffee Consumption with Total and Cause-Specific Mortality in 3 Large Prospective Cohorts.” Circulation 132, no. 24 (2015): 2305–2315.
51. Renouf, M., et al. “Plasma Appearance and Correlation Between Coffee and Green Tea Metabolites in Human Subjects.” British Journal of Nutrition 104, no. 11 (2010): 1635–1640.
52. Ojha, S., et al. “Neuroprotective Potential of Ferulic Acid in the Rotenone Model of Parkinson’s Disease.” Drug Design, Development and Therapy (2015): 5499–5510; Madeira, M. H., et al. “Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases.” Mediators of Inflammation 2017 (2017): 4761081.
53. Ma, Z. C., et al. “Ferulic Acid Induces Heme Oxygenase-1 via Activation of ERK and Nrf2.” Drug Discoveries & Therapeutics 5, no. 6 (2011): 299–305.
54. Graf, E. “Antioxidant Potential of Ferulic Acid.” Free Radical Biology & Medicine 13, no. 4 (1992): 435–448.
55. Ren, Z., et al. “Ferulic Acid Exerts Neuroprotective Effects Against Cerebral Ischemia/ReperfusionInduced Injury via Antioxidant and Anti-Apoptotic Mechanisms In Vitro and In Vivo.” International Journal of Molecular Medicine 40, no. 5 (2017): 1444–1456.
56. Zhao, J., et al. “Ferulic Acid Enhances the Vasorelaxant Effect of Epigallocatechin Gallate in Tumor Necrosis Factor-Alpha-Induced Inflammatory Rat Aorta.” The Journal of Nutritional Biochemistry 25, no. 7 (2014): 807–814; Zhao, J., et al. “Ferulic Acid Enhances Nitric Oxide Production Through Up-Regulation of Argininosuccinate Synthase in Inflammatory Human Endothelial Cells.” Life Sciences 145 (2016): 224–232.
57. O’Keefe, J. H., et al. “Effects of Habitual Coffee Consumption on Cardiometabolic Disease, Cardiovascular Health, and All-Cause Mortality.” Journal of the American College of Cardiology 62, no. 12 (2013): 1043–1051; Neuhauser, B., et al. “Coffee Consumption and Total Body Water Homeostasis as Measured by Fluid Balance and Bioelectrical Impedance Analysis.” Annals of Nutrition and Metabolism 41, no. 1 (1997): 29–36.
58. Massey, L. K., and S. J. Whiting. “Caffeine, Urinary Calcium, Calcium Metabolism and Bone.” Journal of Nutrition 123, no. 9 (1993): 1611–1614.
59. Passmore, A. P., G. B. Kondowe, and G. D. Johnston. “Renal and Cardiovascular Effects of Caffeine: A Dose-Response Study.” Clinical Science (Lond) 72, no. 6 (1987): 749–756.
1. Meneely, G. R., and H. D. Battarbee. “High Sodium-Low Potassium Environment and Hypertension.” American Journal of Cardiology 38, no. 6 (1976): 768–785.
2. Dahl, L. K. “Possible Role of Salt Intake in the Development of Essential Hypertension. 1960.” International Journal of Epidemiology 34, no. 5 (2005): 967–972; discussion 972–974, 975–978.
3. Dahl, L. K. “Salt in Processed Baby Foods.” American Journal of Clinical Nutrition 21, no. 8 (1968): 787–792.
4. См. примечание 2 выше.
5. DiNicolantonio, J. J., and S. C. Lucan. “The Wrong White Crystals: Not Salt but Sugar as Aetiological in Hypertension and Cardiometabolic Disease.” Open Heart 1 (2014): doi:10.1136/openhrt-2014-000167; DiNicolantonio, J. J., S. C. Lucan, and J. H. O’Keefe. “An Unsavory Truth: Sugar, More Than Salt, Predisposes to Hypertension and Chronic Disease.” American Journal of Cardiology 114, no. 7 (2014): 1126–1128.
6. DiNicolantonio, J. J. The Salt Fix: Why the Experts Got It All Wrong – and How Eating More Might Save Your Life. New York: Harmony (2017).
7. Satin, M. “The Salt Debate – Far More Salacious Than Salubrious.” Blood Purification 39, no. 1–3 (2015): 11–15.
8. Gleibermann, L. “Blood Pressure and Dietary Salt in Human Populations.” Ecology of Food and Nutrition 2, no. 2 (1973): 143–156.
9. См. примечание 6 выше.
10. Powles, J., et al. “Global, Regional and National Sodium Intakes in 1990 and 2010: A Systematic Analysis of 24 h Urinary Sodium Excretion and Dietary Surveys Worldwide.” BMJ Open 3, no. 12 (2013). Открыто по адресу https://bmjopen.bmj.com/content/3/12/e003733.
11. См. примечание 8 выше.
12. Ibid.
13. См. примечание 7 выше.
14. Alderman, M. H., H. Cohen, and S. Madhavan. “Dietary Sodium Intake and Mortality: The National Health and Nutrition Examination Survey (NHANES I).” The Lancet 351, no. 9105 (1998): 781–785.
15. Ibid.
16. McGuire, S., Institute of Medicine. 2013. Sodium Intake in Populations: Assessment of Evidence. Washington, DC: The National Academies Press, 2013.
17. Ibid.
18. См. примечание 1 выше.
19. “AACC Members Agree on Definition of Whole Grain.” Открыто по адресу www.aaccnet.org/initiatives/definitions/Documents/WholeGrains/wgflyer.pdf.
20. “Collagen.” https://en.wikipedia.org/wiki/Collagen.
21. Sharp, R. L. “Role of Sodium in Fluid Homeostasis with Exercise.” The Journal of the American College of Nutrition 25, no. 3 Suppl (2006): 231s–239s.
22. См. примечание 5 выше.
23. Stolarz-Skrzypek, K., et al. “Fatal and Nonfatal Outcomes, Incidence of Hypertension, and Blood Pressure Changes in Relation to Urinary Sodium Excretion.” JAMA 30, no. 17 (2011): 1777–1785.
24. Feldman, R. D., and N. D. Schmidt. “Moderate Dietary Salt Restriction Increases Vascular and Systemic Insulin Resistance.” American Journal of Hypertension 12, no. 6 (1999): 643–647.
25. Patel, S. M., et al. “Dietary Sodium Reduction Does Not Affect Circulating Glucose Concentrations in Fasting Children or Adults: Findings from a Systematic Review and Meta-Analysis.” Journal of Nutrition 145, no. 3 (2015): 505–513.
26. Graudal, N. A., A. M. Galloe, and P. Garred. “Effects of Sodium Restriction on Blood Pressure, Renin, Aldosterone, Catecholamines, Cholesterols, and Triglyceride: A Meta-Analysis.” JAMA 279, no. 17 (1998): 1383–1391.
27. См. примечание 6 выше.
28. O’Donnell, M., et al. “Urinary Sodium and Potassium Excretion, Mortality, and Cardiovascular Events.” New England Journal of Medicine 371, no. 7 (2014): 612–623.
29. Graudal, N., et al. “Compared with Usual Sodium Intake, Low– and Excessive-Sodium Diets Are Associated with Increased Mortality: A Meta-Analysis.” American Journal of Hypertension 27, no. 9 (2014): 1129–1137.
30. Folkow, B. “Salt and Blood Pressure – Centenarian Bone of Contention.” Lakartidningen 100, no. 40 (2003): 3142–3147.
31. Liedtke, W. B., et al. “Relation of Addiction Genes to Hypothalamic Gene Changes Subserving Genesis and Gratification of a Classic Instinct, Sodium Appetite.” Proceedings of the National Academy of Sciences of the United States of America 108, no. 30 (2011): 12509–12514.
32. Denton, D. A., M. J. McKinley, and R. S. Weisinger. “Hypothalamic Integration of Body Fluid Regulation.” Proceedings of the National Academy of Sciences of the United States of America 93, no. 14 (1996): 7397–7404.
33. Adler, A. J., et al. “Reduced Dietary Salt for the Prevention of Cardiovascular Disease.” Cochrane Database Systematic Reviews 12 (2014): Cd009217.
34. Kelly, J., et al. “The Effect of Dietary Sodium Modification on Blood Pressure in Adults with Systolic Blood Pressure Less Than 140 mmHg: A Systematic Review.” JBI Database of Systematic Reviews and Implementation Reports 14, no. 6 (2016): 196–237.
35. de Baaij, J. H., J. G. Hoenderop, and R. J. Bindels. “Magnesium in Man: Implications for Health and Disease.” Physiological Reviews 95, no. 1 (2015): 1–46.
36. DiNicolantonio, J. J., J. H. O’Keefe, and W. Wilson. “Subclinical Magnesium Deficiency: A Principal Driver of Cardiovascular Disease and a Public Health Crisis.” Open Heart 5, no. 1 (2018): e000668.
37. Guoa, W., et al. “Magnesium Deficiency on Plants: An Urgent Problem.” The Crop Journal 4, no. 2 (2016): 83–91; Thomas, D. “The Mineral Depletion of Foods Available to Us as a Nation (1940–2002) – A Review of the 6th Edition of McCance and Widdowson.” Nutrition and Health 19, no. 1–2 (2007): 21–55.
38. Temple, N. J. “Refined Carbohydrates – A Cause of Suboptimal Nutrient Intake.” Medical Hypotheses 10, no. 4 (1983): 411–424.
39. Costello, R. B., et al. “Perspective: The Case for an Evidence-Based Reference Interval for Serum Magnesium: The Time Has Come.” Advances in Nutrition